9-128907163-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -12 ACMG points: 0P and 12B. BP4_ModerateBP6_ModerateBS1BS2
The NM_019594.4(LRRC8A):c.-2C>T variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00146 in 1,604,536 control chromosomes in the GnomAD database, including 33 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.0080 ( 14 hom., cov: 32)
Exomes 𝑓: 0.00078 ( 19 hom. )
Consequence
LRRC8A
NM_019594.4 5_prime_UTR
NM_019594.4 5_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: 2.05
Genes affected
LRRC8A (HGNC:19027): (leucine rich repeat containing 8 VRAC subunit A) This gene encodes a protein belonging to the leucine-rich repeat family of proteins, which are involved in diverse biological processes, including cell adhesion, cellular trafficking, and hormone-receptor interactions. This family member is a putative four-pass transmembrane protein that plays a role in B cell development. Defects in this gene cause autosomal dominant non-Bruton type agammaglobulinemia, an immunodeficiency disease resulting from defects in B cell maturation. Multiple alternatively spliced transcript variants, which encode the same protein, have been identified for this gene. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.24).
BP6
Variant 9-128907163-C-T is Benign according to our data. Variant chr9-128907163-C-T is described in ClinVar as [Benign]. Clinvar id is 2920758.Status of the report is criteria_provided_single_submitter, 1 stars.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00795 (1212/152378) while in subpopulation AFR AF= 0.028 (1166/41598). AF 95% confidence interval is 0.0267. There are 14 homozygotes in gnomad4. There are 577 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High AC in GnomAd4 at 1212 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LRRC8A | NM_019594.4 | c.-2C>T | 5_prime_UTR_variant | 3/4 | ENST00000372600.9 | NP_062540.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LRRC8A | ENST00000372600.9 | c.-2C>T | 5_prime_UTR_variant | 3/4 | 1 | NM_019594.4 | ENSP00000361682 | P1 | ||
LRRC8A | ENST00000372599.7 | c.-2C>T | 5_prime_UTR_variant | 2/3 | 1 | ENSP00000361680 | P1 | |||
LRRC8A | ENST00000259324.5 | c.-2C>T | 5_prime_UTR_variant | 3/4 | 2 | ENSP00000259324 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00790 AC: 1203AN: 152260Hom.: 12 Cov.: 32
GnomAD3 genomes
AF:
AC:
1203
AN:
152260
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00212 AC: 527AN: 248472Hom.: 9 AF XY: 0.00150 AC XY: 201AN XY: 134292
GnomAD3 exomes
AF:
AC:
527
AN:
248472
Hom.:
AF XY:
AC XY:
201
AN XY:
134292
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000782 AC: 1135AN: 1452158Hom.: 19 Cov.: 30 AF XY: 0.000626 AC XY: 451AN XY: 720480
GnomAD4 exome
AF:
AC:
1135
AN:
1452158
Hom.:
Cov.:
30
AF XY:
AC XY:
451
AN XY:
720480
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00795 AC: 1212AN: 152378Hom.: 14 Cov.: 32 AF XY: 0.00774 AC XY: 577AN XY: 74522
GnomAD4 genome
AF:
AC:
1212
AN:
152378
Hom.:
Cov.:
32
AF XY:
AC XY:
577
AN XY:
74522
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
6
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Agammaglobulinemia 5, autosomal dominant Benign:1
Benign, criteria provided, single submitter | clinical testing | ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories | Sep 22, 2023 | - - |
LRRC8A-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Aug 28, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at